Chemoinformaics analysis of 4-hydroxy-4-methyl
Molecular Weight | 190.242 | nRot | 3 |
Heavy Atom Molecular Weight | 176.13 | nRig | 8 |
Exact Molecular Weight | 190.099 | nRing | 1 |
Solubility: LogS | -1.852 | nHRing | 0 |
Solubility: LogP | 2.117 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 1 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
nHA | 2 | APOL | 30.9791 |
nHD | 1 | BPOL | 14.9129 |
QED | 0.74 |
Synth | 2.098 |
Natural Product Likeliness | 0.451 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.021 |
Pgp-sub | 0.003 |
HIA | 0.005 |
CACO-2 | -4.407 |
MDCK | 0.0000316 |
BBB | 0.931 |
PPB | 0.880633 |
VDSS | 0.829 |
FU | 0.0823074 |
CYP1A2-inh | 0.709 |
CYP1A2-sub | 0.49 |
CYP2c19-inh | 0.242 |
CYP2c19-sub | 0.815 |
CYP2c9-inh | 0.138 |
CYP2c9-sub | 0.495 |
CYP2d6-inh | 0.008 |
CYP2d6-sub | 0.186 |
CYP3a4-inh | 0.008 |
CYP3a4-sub | 0.426 |
CL | 4.468 |
T12 | 0.828 |
hERG | 0.043 |
Ames | 0.56 |
ROA | 0.511 |
SkinSen | 0.932 |
Carcinogencity | 0.608 |
EI | 0.543 |
Respiratory | 0.312 |
NR-Aromatase | 0.018 |
Antiviral | No |
Prediction | 0.662229 |